Literature DB >> 25331908

No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.

Mette Cathrine Ørngreen1, John Vissing, Pascal Laforét.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25331908     DOI： 10.1007/s10545-014-9779-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Bezafibrate for an inborn mitochondrial beta-oxidation defect.

Authors:  Jean-Paul Bonnefont; Jean Bastin; Anthony Behin; Fatima Djouadi
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

2.  Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.

Authors:  Mette Cathrine Ørngreen; Karen Lindhardt Madsen; Nicolai Preisler; Grete Andersen; John Vissing; Pascal Laforêt
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

3.  Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose.

Authors:  Mette C Ørngreen; David B Olsen; John Vissing
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

4.  Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency.

Authors:  Mette C Ørngreen; Rasmus Ejstrup; John Vissing
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

Review 5.  PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.

Authors:  F Djouadi; J Bastin
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982
  5 in total
  12 in total

Review 1.  Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenji Yamada; Takeshi Taketani
Journal:  J Hum Genet       Date:  2018-11-06       Impact factor: 3.172

2.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

Review 3.  Evidence that Oxidative Disbalance and Mitochondrial Dysfunction are Involved in the Pathophysiology of Fatty Acid Oxidation Disorders.

Authors:  Graziela Schmitt Ribas; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.046

Review 4.  Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease.

Authors:  Bárbara J Henriques; Rikke Katrine Jentoft Olsen; Cláudio M Gomes; Peter Bross
Journal:  Gene       Date:  2021-01-13       Impact factor: 3.688

Review 5.  Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism.

Authors:  Rikke K J Olsen; Nanna Cornelius; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2015-05-30       Impact factor: 4.982

6.  Lipolysis and lipophagy in lipid storage myopathies.

Authors:  Corrado Angelini; Anna Chiara Nascimbeni; Giovanna Cenacchi; Elisabetta Tasca
Journal:  Biochim Biophys Acta       Date:  2016-04-13

7.  The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome.

Authors:  Yan Huang; Corey Powers; Victoria Moore; Caitlin Schafer; Mindong Ren; Colin K L Phoon; Jeanne F James; Alexander V Glukhov; Sabzali Javadov; Frédéric M Vaz; John L Jefferies; Arnold W Strauss; Zaza Khuchua
Journal:  Orphanet J Rare Dis       Date:  2017-03-09       Impact factor: 4.123

Review 8.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.

Authors:  Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  Biosci Rep       Date:  2015-11-20       Impact factor: 3.840

9.  Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.

Authors:  Kenji Yamada; Hideaki Shiraishi; Eishin Oki; Mika Ishige; Toshiyuki Fukao; Yusuke Hamada; Norio Sakai; Fumihiro Ochi; Asami Watanabe; Sanae Kawakami; Kazuyo Kuzume; Kenji Watanabe; Koji Sameshima; Kiyotaka Nakamagoe; Akira Tamaoka; Naoko Asahina; Saki Yokoshiki; Takashi Miyakoshi; Kota Ono; Koji Oba; Toshiyuki Isoe; Hiroshi Hayashi; Seiji Yamaguchi; Norihiro Sato
Journal:  Mol Genet Metab Rep       Date:  2018-02-22

10.  The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.

Authors:  Caitlin Schafer; Vicky Moore; Nupur Dasgupta; Sabzali Javadov; Jeanne F James; Alexander I Glukhov; Arnold W Strauss; Zaza Khuchua
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.